MyMyelomaTeam

CAR-T cell therapy has been used by many individuals with multiple myeloma, particularly those with relapsed or refractory cases. Clinical trials and studies have shown promising results, with some patients achieving remission or significant reduction in cancer. However, it’s important to note that side effects like Show Full Answer

CAR-T cell therapy has been used by many individuals with multiple myeloma, particularly those with relapsed or refractory cases. Clinical trials and studies have shown promising results, with some patients achieving remission or significant reduction in cancer. However, it’s important to note that side effects like cytokine release syndrome (CRS) are common. If you're considering this therapy, consult your doctor to discuss its risks and benefits.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Gene-Based Therapy May Thwart a Tough Blood Cancer | MyMyelomaTeam